SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Kimble Leighann)
 

Search: WFRF:(Kimble Leighann) > Methods to Discover...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias.

Teunissen, Charlotte E (author)
MIRIADE Consortium: Multiomics Interdisciplinary Research Integration to Address Dementia diagnosis, Amsterdam, The Netherlands; Neurochemistry Lab, Department of Laboratory Medicine, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands
Kimble, Leighann (author)
Bayoumy, Sherif (author)
show more...
Bolsewig, Katharina (author)
Burtscher, Felicia (author)
Coppens, Salomé (author)
Das, Shreyasee (author)
Gogishvili, Dea (author)
Fernandes Gomes, Bárbara (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Gómez de San José, Nerea (author)
Mavrina, Ekaterina (author)
Meda, Francisco J, 1997 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Mohaupt, Pablo (author)
Mravinacová, Sára (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab,MIRIADE Consortium: Multiomics Interdisciplinary Research Integration to Address Dementia diagnosis, Amsterdam, The Netherlands
Waury, Katharina (author)
Wojdała, Anna Lidia (author)
Abeln, Sanne (author)
Chiasserini, Davide (author)
Hirtz, Christophe (author)
Gaetani, Lorenzo (author)
Vermunt, Lisa (author)
Bellomo, Giovanni (author)
Halbgebauer, Steffen (author)
Lehmann, Sylvain (author)
Månberg, Anna, 1985- (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab,MIRIADE Consortium: Multiomics Interdisciplinary Research Integration to Address Dementia diagnosis, Amsterdam, The Netherlands
Nilsson, Peter (author)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik,MIRIADE Consortium: Multiomics Interdisciplinary Research Integration to Address Dementia diagnosis, Amsterdam, The Netherlands
Otto, Markus (author)
Vanmechelen, Eugeen (author)
Verberk, Inge M W (author)
Willemse, Eline (author)
Zetterberg, Henrik, 1973 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry,MIRIADE Consortium: Multiomics Interdisciplinary Research Integration to Address Dementia diagnosis, Amsterdam, The Netherlands; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK; UK Dementia Research Institute at UCL, London, UK; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China; Clear Water Bay; Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA
show less...
 (creator_code:org_t)
Elsevier BV, 2023
2023
English.
In: Molecular & cellular proteomics : MCP. - : Elsevier BV. - 1535-9484 .- 1535-9476. ; 22:10
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Neurodegenerative dementias are progressive diseases that cause neuronal network breakdown in different brain regions often because of accumulation of misfolded proteins in the brain extracellular matrix, such as amyloids or inside neurons or other cell types of the brain. Several diagnostic protein biomarkers in body fluids are being used and implemented, such as for Alzheimer's disease. However, there is still a lack of biomarkers for co-pathologies and other causes of dementia. Such biofluid-based biomarkers enable precision medicine approaches for diagnosis and treatment, allow to learn more about underlying disease processes, and facilitate the development of patient inclusion and evaluation tools in clinical trials. When designing studies to discover novel biofluid-based biomarkers, choice of technology is an important starting point. But there are so many technologies to choose among. To address this, we here review the technologies that are currently available in research settings and, in some cases, in clinical laboratory practice. This presents a form of lexicon on each technology addressing its use in research and clinics, its strengths and limitations, and a future perspective.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Keyword

Humans
Alzheimer Disease
Brain
Biomarkers
Neurons
Precision Medicine
Amyloid beta-Peptides

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view